The landscape of dementia analysis has developed drastically with the advent of subtle biomarkers, like amyloid PET scans, tau imaging, and blood-primarily based tests which will detect Alzheimer's pathology a long time prior to indications emerge. While these technological advancements signify extraordinary progress in understanding neurodegenerative conditions, they have not https://abrahamn542qbm3.wikiitemization.com/user